John D. Carroll has a great article on Fierce Biotech today. "The Biggest R&D Spenders in Biotech". 

"Ironically, every new top executive in biotech is ultimately judged by the success or failure of his predecessor's game plan." 

It's short, and to the point, and I'm mentioning it here so you can read it yourself, and add them to your subscriptions. If you aren't getting their newsletter, and you're in this industry, you are definitely missing out.